Company CVAbout Acutaas Chemicals Ltd 
Acutaas Chemicals Ltd
Small Cap
Pharmaceuticals & Biotechnology
Ami Organics Limited was initially formed as a partnership firm in the name of "Ami Organics" with effect from 03 January, 2004 at Surat, India. The Firm converted into a Private Limited Company under the name of "Ami Organics Private Limited" with a Certificate of Incorporation dated 12 June, 2007.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 40.93 Cr
Number of Shares
8.19 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
25-Apr-2025
8.19
40.93
40934461
5
Stock Split
21-Jun-2024
4.09
40.91
3225806
10
Qualified Institutional Placement
31-May-2024
3.77
37.68
799193
10
Preferential basis
25-Sep-2023
3.69
36.88
443500
10
Preferential basis
08-Sep-2021
3.64
36.44
3278688
10
Public Issue
10-Aug-2021
3.32
33.16
1658374
10
Preferential Allotment
31-Mar-2021
3.15
31.50
21000000
10
Bonus Issue
20-Apr-2018
1.05
10.50
9000000
10
Bonus Issue
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 20 Schemes (15.81%)
FIIs
Held by 131 FIIs (16.85%)
Promoter with highest holding
Nareshkumar Ramjibhai Patel (17.69%)
Highest Public shareholder
Kotak Mahindra Trustee Co Ltd A/c Kotak Multicap Fund (3.78%)
Individual Investors Holdings
22.79%
Board of Directors
Management
Designation
Remuneration
Nareshbhai Ramjibhai Patel
Chairman / Executive Director
4.69 cr
Chetankumar Chhaganlal Vaghasia
Whole-time Director
4.62 cr
Virendra Nath Mishra
Whole-time Director
1.32 cr
Ram Mohan Rao Locande
Whole-time Director
1.21 cr
Girikrishna Maniar
Independent Non Exe. Director
20.0 lacs
Hetal Gandhi
Independent Non Exe. Director
20.0 lacs
Richa M. Goyal
Independent Non Exe. Director
10.0 lacs
Anita Bandyopadhyay
Independent Non Exe. Director
10.0 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Materials consumed
566.8402
0%
Cost of Materials consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
306 Cr
(Quarterly Results - Sep 2025)
Net Profit:
72 Cr
Pharmaceuticals & Biotechnology
INR 13,896 Cr (Small Cap)
62.00
40
0.09%
-0.16
15.84%
9.90
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
